LQTSTypen

LQTSTypen refers to the subtypes of Long QT Syndrome (LQTS), a group of inherited cardiac channelopathies characterized by a prolonged QT interval on the electrocardiogram and an increased risk of torsades de pointes, a potentially life-threatening ventricular arrhythmia. The condition often presents with syncope, palpitations, or sudden cardiac death, sometimes triggered by exercise, stress, or sleep.

The most common subtypes are LQT1, LQT2 and LQT3. Each subtype is linked to mutations in a specific gene that encodes a cardiac ion channel: LQT1 is typically caused by mutations in KCNQ1, LQT2 by KCNE2 or KCNH2, and LQT3 by SCN5A. Inheritance is usually autosomal dominant, but there are rarer recessive forms, such as Jervell and Lange-Nielsen syndrome (congenital deafness) and Romano-Ward syndrome (non-syndromic). Other, rarer LQTS subtypes include those associated with genes such as KCNJ2 (Andersen-Tawil syndrome) and CACNA1C (Timothy syndrome), among others.

Clinical presentation varies by subtype, with LQT1 often triggered by physical exertion (especially swimming), LQT2 by emotional or auditory stimuli, and LQT3 events occurring more commonly at rest or during sleep. Diagnosis combines clinical history, a prolonged corrected QT interval on ECG, and genetic testing to identify the subtype and guide family screening.

Management includes lifestyle modifications, avoidance of QT-prolonging drugs, and beta-blocker therapy as first-line treatment. In high-risk individuals, an implantable cardioverter-defibrillator (ICD) may be recommended, and left cervicothoracic sympathectomy can be considered for refractory cases. Family screening and genetic counseling are important due to the hereditary nature of LQTSTypen. Prognosis improves significantly with appropriate diagnosis and management.